hydroxypropyl cellulose

hydroxypropyl cellulose (LACRISERT) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.

LACRISERT is a marketed brand name for hydroxypropyl cellulose. Check FDA Drugs@FDA for the current US label holder and prescribing information.

hydroxypropyl cellulose has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.